AstraZeneca will expand the its global R&D hub in Mississauga. This $820 million investment underscores Ontario’s growing prominence in the life sciences sector and will create more than 700 ...

AstraZeneca PLC AZN-Q is investing $820-million and creating more than 700 jobs in Ontario’s life sciences industry, stimulating growth within a national research and development sector that has ...

Invest Ontario added that it also provided AstraZeneca with site selection services, market intelligence, and immigration support to streamline the investment process. “This investment is a reflection ...

This investment will facilitate the company's move to a larger, advanced office facility in the Greater Toronto Area, Ontario. This new investment is part of AstraZeneca's global goal to achieve ...

AstraZeneca has unveiled plans to invest around ... AZ announced a C$500 million investment in its Global Clinical Hub in Mississauga, Ontario, to expand its research and clinical trials ...

AstraZeneca, a global pharmaceutical company ... state-of-the-art office facility in the Greater Toronto Area (GTA), Ontario. WILMINGTON, Del., January 17, 2025--DATROWAY® (datopotamab deruxtecan ...

Ontario Teachers' Pension Plan CEO Jo Taylor ... 2,000 years ago What giving up bread really does for your health AstraZeneca’s U-turn on £450m Speke expansion ‘deeply disappointing ...

“This investment is a reflection of our growing clinical pipeline, our strong belief in Canada’s potential as a global hub for life sciences innovation, and the value of public-private collaboration ...

AstraZeneca has cancelled plans for a £450m vaccine manufacturing plant in Liverpool, blaming a cut in funding from government. The investment, announced last year in the Tories' spring budget ...

AstraZeneca has abandoned a £450m investment in a major UK vaccine plant just days after Rachel Reeves vowed to “kick-start economic growth”. The drugmaker, which is Britain’s most valuable ...